- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/98 - Nitrogen atom
Patent holdings for IPC class C07D 211/98
Total number of patents in this class: 85
10-year publication summary
|
7
|
4
|
4
|
3
|
9
|
4
|
7
|
6
|
6
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Incyte Corporation | 1015 |
5 |
| Incyte Holdings Corporation | 653 |
5 |
| Alkermes, Inc. | 137 |
4 |
| Mitsui Chemicals Crop & Life Solutions,Inc. | 154 |
4 |
| Bristol-myers Squibb Company | 4875 |
3 |
| Takeda Pharmaceutical Company Limited | 2708 |
3 |
| Ensysce Biosciences, Inc. | 20 |
3 |
| F. Hoffmann-La Roche AG | 7923 |
2 |
| Janssen Pharmaceutica N.V. | 3413 |
2 |
| ACADIA Pharmaceuticals Inc. | 204 |
2 |
| Cytokinetics, Inc. | 272 |
2 |
| Institut de Recherche pour le Developpement (ird) | 149 |
2 |
| Johnson Matthey Public Limited Company | 1842 |
2 |
| OmegaChem Inc. | 4 |
2 |
| Orion Corporation | 608 |
2 |
| Purdue Pharma L.P. | 498 |
2 |
| Receptos LLC | 63 |
2 |
| Hoffmann-La Roche Inc. | 3387 |
1 |
| Samsung Display Co., Ltd. | 34290 |
1 |
| Boehringer Ingelheim International GmbH | 4698 |
1 |
| Other owners | 35 |